Skip NavigationMarketsBusinessInvestingTechPolitics & PolicyVideoWatchlistInvesting ClubPRO
LivestreamMenu
Anna Rodin is an editorial production lead for CNBC Cures, an initiative focused on raising awareness of – and improving outcomes for – the 30 million Americans living with rare diseases.
Latest
Athletes with autism take center court at the US OpenAnna Rodin55 Min AgoBioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatmentBrad Quick|Anna RodinAugust 19, 2026Jazz Pharmaceuticals to acquire Actio Biosciences for $820 millionAnna Rodin|Brad QuickAugust 11, 2026














